Kaplan-Meier analysis showed that the watchful waiting patients with the highest quartile of PDGFRβ expression in tumor stroma had a significantly shorter cancer specific survival compared to the rest (15-year probability of event-free survival (P-EFS) was 67±5% and 34±9% in the two groups) (Figure 4 A). This evidence concerns the gene PDGFRB and cancer.